Matt Hewitt
Stock Analyst at Craig-Hallum
(3.13)
# 1,149
Out of 4,479 analysts
28
Total ratings
45.16%
Success rate
2.14%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Buy | $51 → $56 | $46.86 | +19.50% | 6 | Jun 13, 2024 | |
| NOTV Inotiv | Maintains: Buy | $25 → $10 | $1.61 | +521.12% | 2 | May 16, 2024 | |
| SDGR Schrödinger | Maintains: Buy | $35 → $30 | $20.33 | +47.57% | 3 | May 2, 2024 | |
| CSBR Champions Oncology | Downgrades: Hold | n/a | $4.86 | - | 1 | Mar 13, 2024 | |
| CDMO Avid Bioservices | Maintains: Buy | $22 → $16 | $6.70 | +138.81% | 3 | Dec 8, 2023 | |
| MXCT MaxCyte | Initiates: Buy | $7 | $3.72 | +88.17% | 1 | Nov 29, 2023 | |
| BLFS BioLife Solutions | Maintains: Buy | $29 → $23 | $20.23 | +13.69% | 2 | Aug 10, 2023 | |
| RGEN Repligen | Maintains: Buy | $207 → $200 | $120.14 | +66.47% | 2 | Aug 3, 2023 | |
| OABI OmniAb | Initiates: Buy | $10 | $3.67 | +172.48% | 1 | Apr 13, 2023 | |
| TDOC Teladoc Health | Maintains: Hold | $67 → $30 | $9.40 | +219.15% | 4 | Apr 28, 2022 | |
| ISPC iSpecimen | Initiates: Buy | $20 | $0.29 | +6,684.26% | 1 | Jan 4, 2022 | |
| OMCL Omnicell | Maintains: Buy | n/a | $26.16 | - | 1 | Nov 3, 2021 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | n/a | $84.79 | - | 1 | Oct 21, 2020 |
Simulations Plus
Jun 13, 2024
Maintains: Buy
Price Target: $51 → $56
Current: $46.86
Upside: +19.50%
Inotiv
May 16, 2024
Maintains: Buy
Price Target: $25 → $10
Current: $1.61
Upside: +521.12%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $35 → $30
Current: $20.33
Upside: +47.57%
Champions Oncology
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $4.86
Upside: -
Avid Bioservices
Dec 8, 2023
Maintains: Buy
Price Target: $22 → $16
Current: $6.70
Upside: +138.81%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $3.72
Upside: +88.17%
BioLife Solutions
Aug 10, 2023
Maintains: Buy
Price Target: $29 → $23
Current: $20.23
Upside: +13.69%
Repligen
Aug 3, 2023
Maintains: Buy
Price Target: $207 → $200
Current: $120.14
Upside: +66.47%
OmniAb
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $3.67
Upside: +172.48%
Teladoc Health
Apr 28, 2022
Maintains: Hold
Price Target: $67 → $30
Current: $9.40
Upside: +219.15%
iSpecimen
Jan 4, 2022
Initiates: Buy
Price Target: $20
Current: $0.29
Upside: +6,684.26%
Omnicell
Nov 3, 2021
Maintains: Buy
Price Target: n/a
Current: $26.16
Upside: -
Ligand Pharmaceuticals
Oct 21, 2020
Maintains: Buy
Price Target: n/a
Current: $84.79
Upside: -